ZHOU Jianhong, LI Guisheng, LI Gaofeng, HUANG Jian. Efficacy and safety of docetaxel plus capecitabine as second-line treatment in treating patients with advanced non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2012, (23): 100-101,103.
|
Citation:
|
ZHOU Jianhong, LI Guisheng, LI Gaofeng, HUANG Jian. Efficacy and safety of docetaxel plus capecitabine as second-line treatment in treating patients with advanced non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2012, (23): 100-101,103.
|
ZHOU Jianhong, LI Guisheng, LI Gaofeng, HUANG Jian. Efficacy and safety of docetaxel plus capecitabine as second-line treatment in treating patients with advanced non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2012, (23): 100-101,103.
|
Citation:
|
ZHOU Jianhong, LI Guisheng, LI Gaofeng, HUANG Jian. Efficacy and safety of docetaxel plus capecitabine as second-line treatment in treating patients with advanced non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2012, (23): 100-101,103.
|
DownLoad: